Page last updated: 2024-12-11

gluconasturtiin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gluconasturtiin: hydrolysis yields phenylethyl isothiocyanate; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

gluconasturtiin : An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-phenyl-N-(sulfooxy)propanimidoyl group at the anomeric sulfur. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5464032
CHEMBL ID3140279
CHEBI ID79347
MeSH IDM0410508

Synonyms (10)

Synonym
gluconasturtiin
499-30-9
2-phenylethyl glucosinolate
[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1z)-3-phenyl-n-sulfooxypropanimidothioate
CHEBI:79347
1-s-[(1z)-3-phenyl-n-(sulfooxy)propanimidoyl]-1-thio-beta-d-glucopyranose
CHEMBL3140279
Q412097
HY-N10349
CS-0432634

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The TKTD model was better suited to interpret the survival data than descriptive dose-response analysis (LC(x)), accounting for the fast dissipation of the compounds in the soil."( Time-related survival effects of two gluconasturtiin hydrolysis products on the terrestrial isopod Porcellio scaber.
Ellers, J; Hansen, M; Jager, T; Krommenhoek, T; Roelofs, D; Styrishave, B; van Gestel, CA; van Ommen Kloeke, AE; van Pomeren, M, 2012
)
0.65
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aralkylglucosinolic acidA glucosinolic acid having a aralkyl side chain.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.17)18.7374
1990's0 (0.00)18.2507
2000's7 (29.17)29.6817
2010's12 (50.00)24.3611
2020's4 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.08 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]